These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2124159)

  • 1. The pharmacokinetics of gamma-glutamyl-L-dopa in normal and anephric rats and rats with glycerol-induced acute renal failure.
    Boateng YA; Barber HE; MacDonald TM; Petrie JC; Lee MR; Whiting PH
    Br J Pharmacol; 1990 Oct; 101(2):301-6. PubMed ID: 2124159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional haemodynamic effects of dopamine and its prodrugs L-dopa and gludopa in the rat and in the glycerol-treated rat as a model for acute renal failure.
    Drieman JC; van Kan FJ; Thijssen HH; van Essen H; Smits JF; Struijker Boudier HA
    Br J Pharmacol; 1994 Apr; 111(4):1117-22. PubMed ID: 8032598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The renal handling of dopamine originating from L-dopa and gamma-glutamyl-L-dopa.
    Pestana M; Soares-da-Silva P
    Br J Pharmacol; 1994 Jun; 112(2):417-22. PubMed ID: 8075859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics, bioavailability, metabolism, tissue distribution and urinary excretion of gamma-L-glutamyl-L-dopa in the rat.
    Cummings J; Matheson LM; Maurice L; Smyth JF
    J Pharm Pharmacol; 1990 Apr; 42(4):242-6. PubMed ID: 1974290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism and vascular effects of gamma-L-glutamyl-L-dopa on the isolated rat kidney.
    Barthelmebs M; Caillette A; Ehrhardt JD; Velly J; Imbs JL
    Kidney Int; 1990 Jun; 37(6):1414-22. PubMed ID: 1972967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The protective effect of gamma-glutamyl L-dopa on the glycerol treated rat model of acute renal failure.
    Casson IF; Clayden DA; Cope GF; Lee MR
    Clin Sci (Lond); 1983 Aug; 65(2):159-64. PubMed ID: 6407799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. gamma-L-glutamyl-L-DOPA inhibits Na(+)-phosphate cotransport across renal brush border membranes and increases renal excretion of phosphate.
    de Toledo FG; Thompson MA; Bolliger C; Tyce GM; Dousa TP
    Kidney Int; 1999 May; 55(5):1832-42. PubMed ID: 10231445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition of gamma-glutamyl levodopa (gludopa) after intravenous bolus injection in healthy volunteers.
    Boateng YA; Barber HE; MacDonald TM; Petrie JC; Lee MR
    Br J Clin Pharmacol; 1991 Apr; 31(4):419-22. PubMed ID: 1904753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of gamma-L-glutamyl-L-dopa on phosphate excretion.
    Sadiq S; Berndt TJ; Nath KA; Knox FG
    J Lab Clin Med; 2000 Jan; 135(1):52-6. PubMed ID: 10638694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the renal actions of gamma-L-glutamyl-L-dopa and gamma-L-glutamyl-L-tyrosine in normal man.
    Jeffrey RF; MacDonald TM; Lee MR
    Clin Sci (Lond); 1988 Jan; 74(1):37-40. PubMed ID: 3123118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial acute effects of selective modulation of renal dopamine system by gamma-L-glutamyl-L-dopa in rabbits with congestive heart failure.
    Wang ZQ; Way D; Shimizu K; Fong F; Trigg L; McGrath BP
    J Cardiovasc Pharmacol; 1993 Jun; 21(6):1004-11. PubMed ID: 7687706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Metabolism and vascular effects of gammaglutamyl L-dopa on the isolated kidney of the rat].
    Caillette A; Schmidt M; Ehrhardt JD; Imbs JL
    Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():179-82. PubMed ID: 3142404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal metabolism and effects of the glutamyl derivatives of L-dopa and 5-hydroxytryptophan in man.
    Li Kam Wa TC; Freestone S; Samson RR; Johnston NR; Lee MR
    Clin Sci (Lond); 1996 Aug; 91(2):177-85. PubMed ID: 8795441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of carbidopa and indomethacin on the renal response to gamma-L-glutamyl-L-dopa in normal man.
    Jeffrey RF; MacDonald TM; Marwick K; Lee MR
    Br J Clin Pharmacol; 1988 Feb; 25(2):195-201. PubMed ID: 3129006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of noradrenaline spillover by the dopamine prodrug gamma-L-glutamyl-L-dopa: a central effect?
    McGrath BP; Wang ZQ; Shimizu K; Way D; Secombe J
    Hypertens Res; 1995 Jun; 18 Suppl 1():S113-8. PubMed ID: 8529039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sympatho-inhibitory effects of r-l-glutamyl-l-dopa in conscious rabbits.
    Wang ZQ; Shimizu K; Way D; Secombe J; McGrath BP
    Zhongguo Yao Li Xue Bao; 1994 Jan; 15(1):17-21. PubMed ID: 8010078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dopamine prodrug, gludopa, decreases both renal and extrarenal noradrenaline spillover in conscious rabbits.
    Wang ZQ; Shimizu K; Way D; Secombe J; McGrath BP
    Clin Exp Pharmacol Physiol; 1993 May; 20(5):365-8. PubMed ID: 8324926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The renal and haemodynamic effects of a 10 h infusion of glutamyl-L-dopa in normal man.
    MacDonald TM; Jeffrey RF; Lee MR
    Br J Clin Pharmacol; 1989 Jun; 27(6):811-22. PubMed ID: 2527048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (+)-sulpiride antagonises the renal effects of gamma-L-glutamyl-L-dopa in man.
    MacDonald TM; Jeffrey RF; Freestone S; Lee MR
    Br J Clin Pharmacol; 1988 Feb; 25(2):203-12. PubMed ID: 3129007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrarenal dopamine production and distribution in the rat. Physiological control of sodium excretion.
    Wang ZQ; Siragy HM; Felder RA; Carey RM
    Hypertension; 1997 Jan; 29(1 Pt 2):228-34. PubMed ID: 9039107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.